Virus del moquillo canino, diagnóstico tratamiento y bioseguridad
DOI:
https://doi.org/10.35381/s.v.v8i2.4179Palabras clave:
Moquillo canino, vacunas virales, epidemiología, (Fuente: DeCS)Resumen
Objetivo: analizar el virus del moquillo canino, diagnóstico tratamiento y bioseguridad. Método: Descriptivo documental. Conclusión: La alta prevalencia del CDV en diferentes especies y su capacidad para saltar entre ellas, junto con su impacto en la vida silvestre, refuerzan la necesidad de implementar estrategias de vigilancia epidemiológica robustas y programas de vacunación adaptados a las variantes locales del virus.
Descargas
Citas
Zhao J, Ren Y, Chen J, Zheng J, Sun D. Viral Pathogenesis, Recombinant Vaccines, and Oncolytic Virotherapy: Applications of the Canine Distemper Virus Reverse Genetics System. Viruses. 2020;12(3):339. http://dx.doi.org/10.3390/v12030339
Karki M, Rajak KK, Singh RP. Canine morbillivirus (CDV): a review on current status, emergence and the diagnostics. Virus disease. 2022;33(3):309-321. http://dx.doi.org/10.1007/s13337-022-00779-7
Day MJ, Carey S, Clercx C, et al. Aetiology of Canine Infectious Respiratory Disease Complex and Prevalence of its Pathogens in Europe. J Comp Pathol. 2020;176:86-108. http://dx.doi.org/10.1016/j.jcpa.2020.02.005
Manandhar P, Napit R, Pradhan SM, et al. Phylogenetic characterization of canine distemper virus from stray dogs in Kathmandu Valley. Virol J. 2023;20(1):117. http://dx.doi.org/10.1186/s12985-023-02071-6
Zhao J, Ren Y. Multiple Receptors Involved in Invasion and Neuropathogenicity of Canine Distemper Virus: A Review. Viruses. 2022;14(7):1520. http://dx.doi.org/10.3390/v14071520
Kimpston CN, Hatke AL, Castelli B, et al. High Prevalence of Antibodies against Canine Parvovirus and Canine Distemper Virus among Coyotes and Foxes from Pennsylvania: Implications for the Intersection of Companion Animals and Wildlife. Microbiol Spectr. 2022;10(1):e0253221. http://dx.doi.org/10.1128/spectrum.02532-21
Costanzi L, Brambilla A, Di Blasio A, et al. Beware of dogs! Domestic animals as a threat for wildlife conservation in Alpine protected areas. Eur J Wildl Res. 2021;67(4):70. http://dx.doi.org/10.1007/s10344-021-01510-5
Georoff TA, Ramsay EC, Gyimesi ZS, Kilburn JJ, Sykes JM 4th. Review of canine distemper vaccination use and safety in north american captive large felids (panthera spp.) From 2000 to 2017. J Zoo Wildl Med. 2020;50(4):778-789. http://dx.doi.org/10.1638/2018-0163
Chludzinski E, Ciurkiewicz M, Stoff M, et al. Canine Distemper Virus Alters Defense Responses in an Ex Vivo Model of Pulmonary Infection. Viruses. 2023;15(4):834. http://dx.doi.org/10.3390/v15040834
Wilkes RP. Canine Distemper Virus in Endangered Species: Species Jump, Clinical Variations, and Vaccination. Pathogens. 2022;12(1):57. http://dx.doi.org/10.3390/pathogens12010057
Oleaga Á, Vázquez CB, Royo LJ, et al. Canine distemper virus in wildlife in south-western Europe. Transbound Emerg Dis. 2022;69(4):e473-e485. http://dx.doi.org/10.1111/tbed.14323
Moessner H, Brunt S, Diaz A, Davis A. Coinfection of Canine Distemper Virus and Rabies Virus in Wildlife Samples Submitted for Routine Rabies Testing. J Wildl Dis. 2023;59(2):310-314. http://dx.doi.org/10.7589/JWD-D-21-00158
Alfano F, Lanave G, Lucibelli MG, et al. Canine Distemper Virus in Autochtonous and Imported Dogs, Southern Italy (2014-2021). Animals (Basel). 2022;12(20):2852. http://dx.doi.org/10.3390/ani12202852
Decaro N, Buonavoglia C, Barrs VR. Canine parvovirus vaccination and immunisation failures: Are we far from disease eradication?. Vet Microbiol. 2020;247:108760. http://dx.doi.org/10.1016/j.vetmic.2020.108760
Chen F, Guo Z, Zhang R, et al. Canine distemper virus N protein induces autophagy to facilitate viral replication. BMC Vet Res. 2023;19(1):60. http://dx.doi.org/10.1186/s12917-023-03575-7
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Marcos Adonis Echeverria-Palacios, Mayra Lissette Pandi-Toalombo, Mishell Aracely Masabanda-Guapi , Jaine Labrada-Ching
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
